AOAhmet Afsin Oktay

Ahmet Afsin Oktay

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ahmet Afsin Oktay has a total of 38 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Hypertension and left ventricular geometry: Diagnosis, prognosis, and management

    by Samantha M. Mutai, Namrata Kadambi, Mattin Moazzam, Ahmet Afşin Oktay

    Hypertension remains one of the most prevalent and consequential cardiovascular risk factors worldwide and is a leading cause of heart disease. Hypertensive heart disease may manifest in alterations in left ventricular (LV) geometry, including concentric remodeling, concentric hypertrophy, and eccentric hypertrophy, representing adaptive responses to chronic pressure or volume overload that may progress to maladaptive remodeling and heart failure. LV geometric patterns, defined by LV mass and relative wall thickness, carry important diagnostic and prognostic implications independent of blood pressure levels. This review provides a comprehensive and contemporary overview of the relationship between hypertension and LV geometry. We summarize key determinants of hypertensive LV remodeling, including cumulative blood pressure exposure, sex differences, metabolic comorbidities, obesity, pericardial adiposity, and obstructive sleep apnea. We discuss current approaches to screening and diagnosis, highlighting the strengths and limitations of electrocardiography, echocardiography, and cardiac magnetic resonance imaging. We review emerging applications of artificial intelligence in electrocardiographic and echocardiographic assessment, with particular attention to their potential to improve detection, phenotypic differentiation, and prognostication. We further examine the prognostic significance of LV remodeling in hypertension and review evidence supporting regression of LV hypertrophy through intensive blood pressure control, management of comorbidities, and lifestyle interventions. Early identification and reversal of hypertensive LV remodeling may offer a critical opportunity to prevent progression to heart failure and reduce long-term cardiovascular morbidity and mortality.


  • Open Access

    Validation of a novel Guideline Directed Medical Therapy (GDMT) scoring tool to optimize therapy for patients with heart failure with reduced ejection fraction (HFrEF)

    by Marisol Wences, Henry Okoroike, Thomas Bernier, Ahmet Afsin Oktay

    Background: The mortality benefit of guideline-directed medical therapy (GDMT) for patients with heart failure with reduced ejection fraction (HFrEF) is well established. However, contemporary registry data consistently demonstrates substantial gaps in GDMT optimization. A standardized tool to quantify GDMT optimization and target dose achievement may help identify treatment deficits, guide clinical decision-making, and improve associated patient outcomes. Methods: This retrospective, single-center observational study evaluated the internal validity of a novel GDMT scoring tool to quantify GDMT optimization. Adult patients admitted between September 2022 and September 2023 with HFrEF and outpatient follow-up were included. The primary analysis assessed the association between GDMT optimization at 30 days and the risk of 90-day all-cause hospitalization using multivariable logistic regression. Secondary analyses described GDMT optimization rates at 30 days, quadruple therapy rates, and associations between GDMT optimization and 90-day HF hospitalization and all-cause mortality. Results: Eighty-nine patients met inclusion criteria. At 30 days, 76% of patients (n= 68) achieved a GDMT score of ≥ 5 and 24% (n= 21) had a suboptimal GDMT score of P=0.008 ) though no significant differences were observed for HF hospitalizations (OR 0.55 CI 0.17-1.85, P=0.33 ) or all-cause mortality ( P=0.997 ). Conclusion: An optimized GDMT score of ≥ 5 at 30 days was associated with reduced odds of all-cause readmissions at 90 days ( P=0.008 ).

  • Challenges in the diagnosis and management of hypertrophic cardiomyopathy and the promise of artificial intelligence

    by Isna H. Khaliq, Aum Solanki, Menhel Kinno, Annabelle Santos Volgman, Ahmet Afsin Oktay


  • The Obesity Paradox of Cardiovascular Outcomes in Patients with Diabetes Mellitus

    by Janki Thakker, Isna Khaliq, Nelish S. Ardeshna, Carl J. Lavie, Ahmet Afsin Oktay

    Purpose of Review The “obesity paradox” describes the counterintuitive observation that overweight and mildly obese individuals with cardiovascular disease (CVD) may have better outcomes than those with normal weight. This paradox is particularly intriguing in patients with type-2 diabetes (T2D), where obesity is a well-established risk factor for cardiometabolic complications. Recent Findings Evidence from some epidemiological studies suggested an obesity paradox in mortality risk among patients with T2D. However, confounding factors may influence this association, including reverse causality, differences in risk factor profiles, and adipose tissue distribution. Recent research also questions the reliance on body mass index as an accurate measure of metabolic health, emphasizing the role of alternative anthropometric indices. Summary This review critically evaluates the evidence for the obesity paradox in T2D, explores potential mechanistic explanations, and discusses clinical implications. Understanding the complex interaction between diabetes and obesity in CVD risk is essential for refining obesity management strategies in individuals with T2D and CVD.


  • Open Access

    Cardiovascular Benefits of Dance as a Unique Form of Exercise: A Literature Review

    by Manvita Tatavarthy, Ahmet Afşin Oktay

    Physical activity has well-known benefits in improving multiple risk factors that lead to cardiovascular disease. Dance is a unique form of exercise that is often accessible and modifiable according to the individual’s cultural background and physical abilities. It can increase physical activity levels by creating social engagement. Limited data from intervention studies with small sample sizes and short duration or follow-up suggested that routine participation in dance can improve agility and balance, leading to decreased rates of immobility and depression, which may act as an independent risk factor for cardiovascular disease. It may also assist with blood pressure control in patients with hypertension. Moreover, dance training may improve cardiorespiratory symptoms in individuals with or without heart failure. Studies also suggested that culturally sensitive dance programs may enhance participation and retention of physical activity in various ethnic groups and women. Future research is needed to understand better the potential long-term cardiovascular benefits of dance training and the feasibility of implementing these programs to improve cardiovascular health in special populations.


  • The Role of Obesity as a Cardiac Disease Risk Factor in Patients with Type 2 Diabetes

    by Sushant Koirala, Michael Sunnaa, Thomas Bernier, Ahmet Afsin Oktay

    Purpose of Review Cardiovascular disease (CVD) is the leading cause of death globally and is closely associated with obesity and type 2 diabetes mellitus (T2DM). This review examines the interplay between obesity, T2DM, and CVD, highlighting the increasing prevalence and economic burden of these conditions. Recent Findings Pharmacologic therapies, particularly glucagon-like peptide-1 receptor agonists, show promise in substantial weight loss and subsequent reduction of adverse cardiovascular events in obese individuals with and without diabetes. Summary Obesity significantly contributes to the development of insulin resistance and T2DM, further escalating CVD risk. The common co-occurrence of these three conditions may involve several other pathophysiological mechanisms, such as chronic inflammation, increased visceral adiposity, and endothelial dysfunction. Until recently, lifestyle modifications and bariatric surgery had been the primary methods for weight loss and mitigating obesity-associated cardiovascular risk. Newer pharmacological options have led to a paradigm shift in our approach to obesity management as they provide substantial benefits in weight loss, glycemic control, and cardiovascular risk reduction.


  • Prevention and treatment of hypertensive left ventricular hypertrophy

    by Manvita Tatavarthy, John Stathopoulos, Ahmet Afşin Oktay

    Purpose of review: Left ventricular (LV) hypertrophy (LVH) is a well recognized target organ adaptation to longstanding uncontrolled hypertension and other cardiovascular risk factors. It is also a strong and independent predictor of many cardiovascular disorders. Recent findings: This focused review explores the current concepts in screening, diagnosis, prevention, and treatment of LVH in patients with hypertension. Currently, the primary screening and diagnostic tools for LVH are ECG and 2D echocardiography. Implementing machine learning in the diagnostic modalities can improve sensitivity in the detection of LVH. Lifestyle modifications, blood pressure control with antihypertensive therapy, and management of comorbidities aid in preventing and reversing LV remodeling. Summary: LVH is a common and often silent complication of hypertension. Prevention and reversal of LV remodeling are crucial for cardiovascular risk reduction in patients with hypertension.


  • The complex interplay between diabetes mellitus and atrial fibrillation

    by Mehmet Yildiz, Carl J. Lavie, Daniel P. Morin, Ahmet Afsin Oktay

    : A growing body of evidence suggests that diabetes mellitus (DM) is associated with an increased risk of new-onset atrial fibrillation (AF) and contributes to suboptimal arrhythmia control and poo...


  • Editorial commentary: COVID-19 as a cardiovascular disease risk factor

    by Ahmet Afşin Oktay, Tisha Marie Suboc, Annabelle Santos Volgman